General Practice
Return Patient Visit
Follow-up documentation with automatic longitudinal awareness — Notat surfaces changes since last visit.
Pasient
52-year-old female, return patient (last seen 3 months ago)
Interval History
Patient returns for T2DM follow-up. Reports improved energy levels since last visit. Checking blood glucose 2-3x weekly: fasting readings mostly 110-140 mg/dL. Denies polyuria, polydipsia, blurred vision, or numbness/tingling in extremities. No hypoglycemic episodes.
Changes Since Last Visit
- Started daily 20-min walks after dinner (adherent)
- Reduced sugary beverage intake significantly
- Lost 4 lbs since last visit (current BMI 29.8, down from 30.4)
Medications
Metformin 1000 mg BID (tolerating well, no GI side effects currently)
Rosuvastatin 10 mg daily
Lisinopril 10 mg daily
All medications confirmed current and taken as prescribed.
Vital Signs
BP 128/82 (improved from 142/88 at last visit)
HR 72, RR 16, Weight 174 lb (-4 lbs)
BMI 29.8
Labs (today)
HbA1c: 7.2% (down from 8.4% at last visit)
Fasting glucose: 118 mg/dL
Lipid panel: Total 185, LDL 89 (down from 107), HDL 52, TG 122
BMP: Na 140, K 4.2, Cr 0.9, eGFR >60 — all WNL
Foot Exam
Intact sensation to monofilament. No ulcers, calluses, or deformities. Pulses 2+ dorsalis pedis and posterior tibial bilaterally.
Assessment & Plan
T2DM — improving. HbA1c goal <7.0 approached.
1. Continue metformin 1000 mg BID — effective and well-tolerated
2. Continue rosuvastatin 10 mg — LDL now at goal (<100)
3. Continue lisopril 10 mg — BP at goal
4. Lifestyle: maintain walking routine, continue dietary modifications
5. Retinal eye exam referral (due annually per ADA guidelines)
6. Return in 3 months — repeat HbA1c, lipid panel, BMP
This is what Notat generates — automatically.
No template selection required. Start recording your consultation and get structured clinical notes tailored to your specialty.
Try Free →